BioCryst Pharmaceuticals Inc
BCRXHealthcare|Drug Manufacturers - Specialty & Generic|USA
$10.45
-0.27 (-2.52%)
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (241)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| McKee Amy E | Director | 2026-05-18 | SELL | 11,180 | $8.97 | $100.3K |
| Barnes Alane P | Chief Legal Officer | 2026-05-13 | SELL | 62,500 | $9.54 | $596.3K |
| HEGGIE THERESA | Director | 2026-03-20 | SELL | 49,933 | $10.11 | $504.8K |
| Barnes Alane P | Chief Legal Officer | 2026-03-16 | SELL | 150,000 | $9.15 | $1372.5K |
| Barnes Alane P | Chief Legal Officer | 2025-12-22 | SELL | 21,773 | $7.65 | $166.6K |
| Barnes Alane P | Chief Legal Officer | 2025-12-15 | SELL | 21,210 | $7.65 | $162.3K |
| Barnes Alane P | Chief Legal Officer | 2025-12-03 | SELL | 161,680 | $7.21 | $1165.7K |
| SANDERS MACHELLE | Director | 2025-11-13 | SELL | 9,600 | $7.14 | $68.5K |
| HEGGIE THERESA | Director | 2025-08-13 | SELL | 70,000 | $8.51 | $595.7K |
| Hutson Nancy J | Director | 2024-12-13 | SELL | 7,000 | $7.54 | $52.8K |
| McKee Amy E | Director | 2024-06-24 | SELL | 8,600 | $6.32 | $54.4K |
| SANDERS MACHELLE | Director | 2024-06-17 | SELL | 4,689 | $6 | $28.1K |
| HEGGIE THERESA | Director | 2024-06-14 | SELL | 6,698 | $6.11 | $40.9K |
| LEVIN ALAN G | Director | 2024-05-30 | BUY | 7,861 | $6.36 | $50K |
| ASELAGE STEVE | Director | 2024-05-24 | BUY | 2,500 | $6.4 | $16K |
| Hutson Nancy J | Director | 2024-05-20 | BUY | 5,000 | $6.38 | $31.9K |
| MILANO VINCENT | Director | 2024-05-20 | BUY | 15,000 | $6.25 | $93.8K |
| Doyle Anthony | CFO | 2024-05-14 | BUY | 36,300 | $5.57 | $202.2K |
| Thackray Helen M. | Chief R&D Officer | 2024-05-14 | BUY | 30,000 | $5.86 | $175.8K |
| Galson Steven K | Director | 2024-05-13 | BUY | 21,940 | $5.49 | $120.5K |
| Barnes Alane P | Chief Legal Officer | 2024-05-13 | BUY | 5,000 | $5.53 | $27.7K |
| Stonehouse Jon P | President & CEO | 2024-05-13 | BUY | 30,000 | $5.55 | $166.5K |
| Gayer Charles K | Chief Commercial Officer | 2024-05-13 | BUY | 30,000 | $5.47 | $164.1K |
| SANDERS MACHELLE | Director | 2023-06-15 | SELL | 4,000 | $7.98 | $31.9K |
| Hutson Nancy J | Director | 2023-06-14 | SELL | 12,866 | $8.04 | $103.4K |
| Thackray Helen M. | Chief R&D Officer | 2023-04-03 | SELL | 7,000 | $8.29 | $58K |
| Stonehouse Jon P | President & CEO | 2023-02-01 | SELL | 100,000 | $10.38 | $1038K |
| Barnes Alane P | Chief Legal Officer | 2022-12-15 | SELL | 4,175 | $10.88 | $45.4K |
| Stonehouse Jon P | President & CEO | 2022-12-15 | SELL | 14,100 | $10.9 | $153.7K |
| Thackray Helen M. | Chief R&D Officer | 2022-12-15 | SELL | 3,125 | $10.89 | $34K |
| Doyle Anthony | CFO | 2022-12-15 | SELL | 5,700 | $10.9 | $62.1K |
| Gayer Charles K | Chief Commercial Officer | 2022-12-15 | SELL | 6,100 | $10.9 | $66.5K |
| Jones Michael L | Exec. Director, Finance - PAO | 2022-12-15 | SELL | 445 | $10.9 | $4.9K |
| Stonehouse Jon P | President & CEO | 2022-12-02 | SELL | 297,573 | $12.94 | $3850.6K |
| Jones Michael L | Exec. Director, Finance - PAO | 2022-12-01 | SELL | 8,600 | $13.01 | $111.9K |
| Babu Yarlagadda S | Chief Discovery Officer | 2022-11-14 | SELL | 31,515 | $13.88 | $437.4K |
| ABERCROMBIE GEORGE B | Director | 2022-04-18 | SELL | 5,000 | $11.04 | $55.2K |
| Sheridan William P | Chief Medical Officer | 2022-03-10 | SELL | 161,139 | $16.88 | $2720K |
| Babu Yarlagadda S | Chief Discovery Officer | 2022-03-07 | SELL | 20,000 | $17.16 | $343.2K |
| ABERCROMBIE GEORGE B | Director | 2022-02-15 | SELL | 5,000 | $18.5 | $92.5K |
| Stonehouse Jon P | President & CEO | 2022-01-11 | SELL | 184,000 | $15.04 | $2767.4K |
| Babu Yarlagadda S | Chief Discovery Officer | 2021-12-07 | SELL | 30,100 | $12.2 | $367.2K |
| MILANO VINCENT | Director | 2021-11-24 | BUY | 7,500 | $12.19 | $91.4K |
| Doyle Anthony | CFO | 2021-11-23 | BUY | 35,258 | $12.48 | $440K |
| ABERCROMBIE GEORGE B | Director | 2021-11-15 | SELL | 5,000 | $12.27 | $61.4K |
| Hutson Nancy J | Director | 2021-10-15 | SELL | 105,000 | $15.4 | $1617K |
| ABERCROMBIE GEORGE B | Director | 2021-09-15 | SELL | 5,000 | $15.06 | $75.3K |
| LEE KENNETH B JR | Director | 2021-09-13 | SELL | 6,000 | $15.35 | $92.1K |
| ABERCROMBIE GEORGE B | Director | 2021-09-10 | SELL | 74,000 | $15.09 | $1116.7K |
| ABERCROMBIE GEORGE B | Director | 2021-07-15 | SELL | 5,000 | $15.69 | $78.5K |
| Hutson Nancy J | Director | 2021-06-10 | SELL | 23,333 | $16.86 | $393.4K |
| ABERCROMBIE GEORGE B | Director | 2021-05-24 | SELL | 6,667 | $13.9 | $92.7K |
| Barnes Alane P | Chief Legal Officer | 2021-05-11 | SELL | 102,780 | $12.04 | $1237.5K |
| ABERCROMBIE GEORGE B | Director | 2021-05-10 | SELL | 7,000 | $12.7 | $88.9K |
| Sheridan William P | Senior VP - CMO | 2021-02-22 | SELL | 41,250 | $11.57 | $477.3K |
| Stonehouse Jon P | President & CEO | 2020-12-15 | SELL | 134,278 | $8.32 | $1117.2K |
| Barnes Alane P | Senior VP, Chief Legal Officer | 2020-12-11 | SELL | 13,741 | $7.96 | $109.4K |
| Barnes Alane P | Senior VP, Chief Legal Officer | 2020-12-04 | SELL | 13,741 | $6.23 | $85.6K |
| Doyle Anthony | CFO | 2020-08-11 | BUY | 54,000 | $4.08 | $220.3K |
| ASELAGE STEVE | Director | 2019-11-18 | BUY | 15,000 | $1.45 | $21.8K |
| Stonehouse Jon P | President & CEO | 2019-11-18 | BUY | 50,000 | $1.45 | $72.5K |
| Sniecinski Megan | Chief Business Officer | 2019-11-18 | BUY | 45,000 | $1.45 | $65.3K |
| LEE KENNETH B JR | Director | 2019-11-18 | BUY | 5,000 | $1.45 | $7.3K |
| INGRAM ROBERT ALEXANDER | Director | 2019-11-18 | BUY | 20,000 | $1.45 | $29K |
| Hutson Nancy J | Director | 2019-11-18 | BUY | 10,000 | $1.45 | $14.5K |
| HEGGIE THERESA | Director | 2019-11-18 | BUY | 5,000 | $1.45 | $7.3K |
| Barnes Alane P | Senior VP, Chief Legal Officer | 2019-11-18 | BUY | 20,000 | $1.45 | $29K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2019-11-18 | BUY | 25,000 | $1.45 | $36.3K |
| ASELAGE STEVE | Director | 2019-05-22 | BUY | 3,000 | $3.57 | $10.7K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-05-17 | SELL | 9,750 | $7.65 | $74.6K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-05-15 | SELL | 11,750 | $7.81 | $91.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-05-13 | SELL | 19,500 | $7.7 | $150.2K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-05-06 | SELL | 16,750 | $7.54 | $126.3K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-04-04 | SELL | 7,500 | $8.81 | $66.1K |
| ASELAGE STEVE | Director | 2019-03-12 | BUY | 2,000 | $8.3 | $16.6K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2019-01-28 | SELL | 5,000 | $9.85 | $49.3K |
| Powell Lynne | Senior VP - CCO | 2019-01-28 | SELL | 12,000 | $9.75 | $117K |
| Powell Lynne | Senior VP - CCO | 2019-01-18 | SELL | 2,000 | $9.4 | $18.8K |
| Powell Lynne | Senior VP - CCO | 2019-01-16 | SELL | 3,046 | $9.27 | $28.2K |
| Powell Lynne | Senior VP - CCO | 2019-01-14 | SELL | 954 | $9.2 | $8.8K |
| Sheridan William P | Senior VP - CMO | 2018-12-18 | SELL | 20,488 | $7.58 | $155.3K |
| Powell Lynne | Senior VP - CCO | 2018-12-10 | SELL | 4,000 | $9.06 | $36.2K |
| Barnes Alane P | Senior VP, Chief Legal Officer | 2018-11-30 | SELL | 44,290 | $9.07 | $401.7K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-11-23 | SELL | 15,500 | $9.32 | $144.5K |
| Powell Lynne | Senior VP - CCO | 2018-11-21 | SELL | 14,455 | $9.05 | $130.8K |
| Powell Lynne | Senior VP - CCO | 2018-11-20 | SELL | 15,470 | $8.55 | $132.3K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-11-20 | SELL | 11,198 | $8.67 | $97.1K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-11-08 | SELL | 14,087 | $8.12 | $114.4K |
| Powell Lynne | Senior VP - CCO | 2018-11-08 | SELL | 5,580 | $8.14 | $45.4K |
| Powell Lynne | Senior VP - CCO | 2018-11-05 | SELL | 100 | $8 | $0.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-11-05 | SELL | 215 | $8 | $1.7K |
| Powell Lynne | Senior VP - CCO | 2018-11-02 | SELL | 1,000 | $8 | $8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-11-02 | SELL | 10,856 | $7.84 | $85.1K |
| Powell Lynne | Senior VP - CCO | 2018-11-01 | SELL | 1,544 | $7.51 | $11.6K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-10-19 | SELL | 3,150 | $7.45 | $23.5K |
| Powell Lynne | Senior VP - CCO | 2018-10-19 | SELL | 100 | $7.5 | $0.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2018-10-03 | SELL | 9,850 | $7.24 | $71.3K |
| Sheridan William P | Senior VP - CMO | 2018-08-09 | SELL | 62,500 | $7.03 | $439.4K |
| Sheridan William P | Senior VP - CMO | 2018-06-01 | SELL | 42,112 | $6.3 | $265.3K |
| Sheridan William P | Senior VP - CMO | 2017-11-13 | SELL | 64,310 | $4.72 | $303.5K |
| Cohen Fred E | Director | 2017-09-18 | SELL | 54,250 | $5.42 | $294K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2017-03-20 | SELL | 3,250 | $9.2 | $29.9K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2017-03-10 | SELL | 3,250 | $9.06 | $29.4K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2017-03-08 | SELL | 6,500 | $8.43 | $54.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2017-03-06 | SELL | 3,250 | $7.9 | $25.7K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2016-12-19 | SELL | 3,250 | $7.45 | $24.2K |
| Barnes Alane P | VP, General Counsel & Corp Sec | 2016-09-14 | SELL | 8,357 | $4.27 | $35.7K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2016-08-25 | SELL | 30,000 | $4.06 | $121.8K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-08-16 | SELL | 4,046,590 | $5 | $20233K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2016-08-12 | SELL | 5,864 | $5.18 | $30.4K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2016-08-09 | SELL | 14,577 | $4.43 | $64.6K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-02-05 | BUY | 45,000 | $6.33 | $284.9K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-02-04 | BUY | 207,715 | $6.43 | $1335.6K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-01-28 | BUY | 88,345 | $6.95 | $614K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-01-22 | BUY | 106,800 | $7.28 | $777.5K |
| BAKER BROS. ADVISORS LP | 10% Owner | 2016-01-20 | BUY | 344,895 | $7.28 | $2510.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-12-21 | SELL | 3,052 | $10.86 | $33.1K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-12-17 | SELL | 3,000 | $10.49 | $31.5K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-07-20 | SELL | 3,500 | $16.5 | $57.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-06-22 | SELL | 3,750 | $16 | $60K |
| Barnes Alane P | VP, General Counsel & Corp Sec | 2015-06-19 | SELL | 3,000 | $15 | $45K |
| Sheridan William P | Senior VP - CMO | 2015-06-19 | SELL | 70,389 | $15.05 | $1059.4K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-06-19 | SELL | 16,375 | $14.36 | $235.1K |
| Stonehouse Jon P | President & CEO | 2015-06-19 | SELL | 20,000 | $15.02 | $300.4K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-06-05 | SELL | 6,000 | $12.75 | $76.5K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2015-05-18 | SELL | 3,000 | $11 | $33K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2015-03-19 | SELL | 12,105 | $10.16 | $123K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2015-03-05 | SELL | 37,400 | $10.59 | $396.1K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2015-03-04 | SELL | 10,495 | $10.5 | $110.2K |
| Hutson Nancy J | Director | 2015-02-20 | BUY | 10,000 | $10.27 | $102.7K |
| Sheridan William P | Senior VP - CMO | 2014-12-30 | SELL | 128,399 | $12.36 | $1587K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-12-29 | SELL | 9,500 | $12.56 | $119.3K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-08-27 | SELL | 10,000 | $13.58 | $135.8K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-07-01 | SELL | 3,125 | $13 | $40.6K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-06-23 | SELL | 3,125 | $12.49 | $39K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-06-17 | SELL | 3,125 | $12 | $37.5K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-03-14 | SELL | 3,125 | $11.24 | $35.1K |
| LEE KENNETH B JR | Director | 2014-03-06 | SELL | 12,665 | $12.69 | $160.7K |
| STAAB THOMAS R II | Senior Vice President and CFO | 2014-03-04 | SELL | 3,000 | $12.69 | $38.1K |
| Babu Yarlagadda S | Senior VP - Drug Discovery | 2014-03-04 | SELL | 40,642 | $12.57 | $510.9K |
| Barnes Alane P | VP, General Counsel & Corp Sec | 2014-03-04 | SELL | 40,734 | $12.63 | $514.5K |
| ABERCROMBIE GEORGE B | Director | 2013-11-12 | BUY | 3,000 | $6.19 | $18.6K |
| BAKER FELIX | 10% Owner | 2013-08-01 | BUY | 1,136,364 | $4.4 | $5000K |
| ABERCROMBIE GEORGE B | Director | 2013-03-05 | BUY | 3,000 | $1.23 | $3.7K |
| Jensen Peder | Director | 2012-12-14 | BUY | 20,000 | $1.51 | $30.2K |
| Jensen Peder | Director | 2012-06-05 | BUY | 20,000 | $3.18 | $63.6K |
| SANDERS CHARLES A | Director | 2012-03-13 | BUY | 2,000 | $5.22 | $10.4K |
| SANDERS CHARLES A | Director | 2012-03-13 | BUY | 2,000 | $5.2 | $10.4K |
| McCullough David | VP | 2012-03-02 | SELL | 574 | $4.78 | $2.7K |
| Babu Yarlagadda S | VP Drug Discovery | 2012-03-02 | SELL | 837 | $4.78 | $4K |
| Sheridan William P | SR VP - CMO | 2012-03-02 | SELL | 956 | $4.78 | $4.6K |
| Stonehouse Jon P | President & CEO | 2012-03-02 | SELL | 2,721 | $4.78 | $13K |
| Babu Yarlagadda S | VP Drug Discovery | 2012-02-22 | SELL | 30,912 | $4.22 | $130.4K |
| McCullough David | VP | 2012-01-03 | SELL | 60,624 | $2.45 | $148.5K |
| McCullough David | VP | 2011-12-07 | SELL | 4,542 | $2.85 | $12.9K |
| Jensen Peder | Director | 2011-11-18 | BUY | 10,000 | $2.75 | $27.5K |
| Stonehouse Jon P | President & CEO | 2011-08-08 | BUY | 10,000 | $2.52 | $25.2K |
| Jensen Peder | Director | 2011-05-12 | BUY | 10,000 | $3.56 | $35.6K |
| Stonehouse Jon P | President & CEO | 2011-03-18 | BUY | 10,000 | $3.4 | $34K |
| Grant Stuart | SR VP & CFO | 2011-03-16 | SELL | 22,615 | $3.39 | $76.7K |
| Grant Stuart | SR VP & CFO | 2010-08-04 | SELL | 2,500 | $6.2 | $15.5K |
| Grant Stuart | SR VP & CFO | 2010-06-03 | SELL | 1,250 | $6.97 | $8.7K |
| Grant Stuart | SR VP & CFO | 2010-05-03 | SELL | 1,250 | $7.68 | $9.6K |
| Grant Stuart | SR VP & CFO | 2010-04-29 | SELL | 38,553 | $8.31 | $320.4K |
| Grant Stuart | SR VP & CFO | 2010-04-12 | SELL | 509 | $8.26 | $4.2K |
| Sheridan William P | SR VP - CMO | 2010-04-08 | SELL | 18,593 | $8.01 | $148.9K |
| Grant Stuart | SR VP & CFO | 2010-04-05 | SELL | 1,249 | $6.96 | $8.7K |
| HOROVITZ ZOLA P | Director | 2010-03-15 | SELL | 10,000 | $7.22 | $72.2K |
| Mills Mike | Principal Accounting Officer | 2010-03-12 | SELL | 1,500 | $7.31 | $11K |
| Grant Stuart | SR VP & CFO | 2010-03-03 | SELL | 15,000 | $6.96 | $104.4K |
| Mills Mike | Principal Accounting Officer | 2010-02-10 | SELL | 5,146 | $7.05 | $36.3K |
| SANDERS CHARLES A | Director | 2010-02-08 | BUY | 5,000 | $6.66 | $33.3K |
| HOROVITZ ZOLA P | Director | 2010-02-01 | SELL | 10,000 | $6.85 | $68.5K |
| Grant Stuart | SR VP & CFO | 2010-01-22 | SELL | 17,027 | $7.02 | $119.5K |
| McCullough David | VP | 2010-01-22 | SELL | 14,271 | $7.02 | $100.2K |
| Sheridan William P | SR VP - CMO | 2010-01-11 | SELL | 4,166 | $8.05 | $33.5K |
| Sheridan William P | SR VP - CMO | 2009-12-01 | SELL | 4,167 | $8.17 | $34K |
| FEATHERINGILL WILLIAM W | Director, 10% Owner | 2009-12-01 | SELL | 147,200 | $8.06 | $1186.4K |
| FEATHERINGILL WILLIAM W | Director, 10% Owner | 2009-11-23 | SELL | 13,800 | $9.56 | $131.9K |
| FEATHERINGILL WILLIAM W | Director, 10% Owner | 2009-11-20 | SELL | 439,000 | $9.65 | $4236.4K |
| Babu Yarlagadda S | VP Drug Discovery | 2009-10-26 | SELL | 6,400 | $10.85 | $69.4K |
| Babu Yarlagadda S | VP Drug Discovery | 2009-10-21 | SELL | 200 | $10 | $2K |
| Babu Yarlagadda S | VP Drug Discovery | 2009-10-20 | SELL | 3,400 | $10 | $34K |
| Sheridan William P | SR VP - CMO | 2009-10-14 | SELL | 6,000 | $8.92 | $53.5K |
| Babu Yarlagadda S | VP Drug Discovery | 2009-09-23 | SELL | 20,000 | $9.14 | $182.8K |
| Mills Mike | Principal Accounting Officer | 2009-07-23 | SELL | 1,500 | $8.26 | $12.4K |
| Mills Mike | Principal Accounting Officer | 2009-07-23 | SELL | 1,500 | $8.26 | $12.4K |
| Mills Mike | Principal Accounting Officer | 2009-07-23 | SELL | 1,500 | $8.26 | $12.4K |
| Mills Mike | Principal Accounting Officer | 2009-07-17 | SELL | 968 | $6 | $5.8K |
| Baker Biotech Capital (GP), LL | 10% Owner | 2009-06-01 | SELL | 236,478 | $4.22 | $997.9K |
| 14159 capital (GP), LLC | 10% Owner | 2009-06-01 | SELL | 15,860 | $4.22 | $66.9K |
| Baker Bros. Capital (GP), LLC | 10% Owner | 2009-06-01 | SELL | 37,719 | $4.22 | $159.2K |
| Baker / Tisch Capital (GP), LL | 10% Owner | 2009-06-01 | SELL | 10,085 | $4.22 | $42.6K |
| Baker Brothers Life Sciences C | 10% Owner | 2009-06-01 | SELL | 516,932 | $4.22 | $2181.5K |
| Erck Stanley C | Director | 2009-03-12 | BUY | 40,000 | $1.22 | $48.8K |
| Sheridan William P | SR VP - CMO | 2009-01-30 | BUY | 3,000 | $1.62 | $4.9K |
| Grant Stuart | SR VP & CFO | 2009-01-30 | BUY | 3,000 | $1.62 | $4.9K |
| Stonehouse Jon P | President & CEO, Director | 2009-01-30 | BUY | 3,000 | $1.62 | $4.9K |
| Stonehouse Jon P | President & CEO, Director | 2008-12-01 | BUY | 55,000 | $1.48 | $81.4K |
| Baker Bros. Capital (GP), LLC | 10% Owner | 2008-11-24 | BUY | 432 | $1 | $0.4K |
| Baker Brothers Life Sciences C | 10% Owner | 2008-11-24 | BUY | 310,918 | $1 | $310.9K |
| Baker Biotech Capital (GP), LL | 10% Owner | 2008-11-24 | BUY | 98,372 | $1 | $98.4K |
| 14159 capital (GP), LLC | 10% Owner | 2008-11-24 | BUY | 8,479 | $1 | $8.5K |
| Baker / Tisch Capital (GP), LL | 10% Owner | 2008-11-24 | BUY | 2,077 | $1 | $2.1K |
| Stonehouse Jon P | President & CEO, Director | 2008-11-03 | BUY | 25,000 | $1.75 | $43.8K |
| Stonehouse Jon P | President & CEO, Director | 2008-08-12 | BUY | 2,300 | $3.1 | $7.1K |
| Stonehouse Jon P | President & CEO, Director | 2008-08-11 | BUY | 7,700 | $2.95 | $22.7K |
| Grant Stuart | SR VP & CFO | 2008-08-04 | BUY | 3,000 | $2.82 | $8.5K |
| Stonehouse Jon P | President & CEO, Director | 2008-08-04 | BUY | 240 | $2.82 | $0.7K |
| DARWIN MICHAEL A | Principal Accounting Officer | 2008-07-31 | BUY | 1,709 | $2.82 | $4.8K |
| BENNETT J CLAUDE | COO | 2007-09-04 | SELL | 20,000 | $12 | $240K |
| Stonehouse Jon P | President & CEO | 2007-08-14 | BUY | 9,900 | $9.9 | $98K |
| FEATHERINGILL WILLIAM W | Director | 2007-08-06 | BUY | 831,538 | $7.8 | $6486K |
| Stonehouse Jon P | CEO | 2007-07-31 | BUY | 2,463 | $7.05 | $17.4K |
| Nugent Jonathan M | VP Corp Communications | 2007-07-31 | BUY | 285 | $7.05 | $2K |
| ALEXANDER W JAMES | SR. VP, Chief Medical Officer | 2007-07-31 | BUY | 2,374 | $7.05 | $16.7K |
| Nugent Jonathan M | VP Corp Communications | 2007-01-31 | BUY | 223 | $8.64 | $1.9K |
| RIGGS RANDALL B | Senior VP Business Development | 2007-01-31 | BUY | 1,184 | $8.64 | $10.2K |
| Nugent Jonathan M | VP Corp Communications | 2006-09-01 | SELL | 5,600 | $10.19 | $57.1K |
| ALEXANDER W JAMES | SR. VP, Chief Medical Officer | 2006-08-14 | BUY | 1,285 | $9 | $11.6K |
| RIGGS RANDALL B | Senior VP Business Development | 2006-07-31 | BUY | 744 | $9.69 | $7.2K |
| BENNETT J CLAUDE | President | 2006-05-10 | BUY | 6,563 | $6.5 | $42.7K |
| BENNETT J CLAUDE | President | 2006-05-03 | SELL | 26,243 | $15.13 | $397.1K |
| SEIDENBERG BETH C | Director | 2006-05-03 | BUY | 3,000 | $15.34 | $46K |
| BENNETT J CLAUDE | President | 2006-04-03 | SELL | 10,000 | $18.02 | $180.2K |
| DARWIN MICHAEL A | CFO | 2006-03-15 | SELL | 22,650 | $19.21 | $435.1K |
| BUGG CHARLES E | Chairman | 2006-03-03 | SELL | 50,000 | $20.64 | $1032K |
| BENNETT J CLAUDE | President | 2006-03-03 | SELL | 10,000 | $21 | $210K |
| RIGGS RANDALL B | Senior VP Business Development | 2006-03-03 | SELL | 1,512 | $20.38 | $30.8K |
| BENNETT J CLAUDE | President | 2006-02-13 | SELL | 3,000 | $16.94 | $50.8K |
| FEATHERINGILL WILLIAM W | Director | 2006-02-10 | SELL | 16,200 | $16.49 | $267.1K |
| GORDON CARL L | Director | 2005-12-02 | SELL | 566,667 | $14.68 | $8318.7K |
| BUGG CHARLES E | CEO, Chairman | 2005-09-26 | SELL | 95,000 | $10 | $950K |
| BUGG CHARLES E | CEO | 2004-04-27 | SELL | 85,000 | $9.51 | $808.4K |
| DARWIN MICHAEL A | CFO | 2004-03-12 | SELL | 5,310 | $8.05 | $42.7K |
| HOROVITZ ZOLA P | Director | 2003-11-14 | SELL | 22,000 | $8.3 | $182.6K |
| MONTGOMERY JOHN A | Director | 2003-11-04 | SELL | 40,000 | $8.5 | $340K |
| BVF PARTNERS L P/IL | 2003-10-27 | SELL | 746,000 | $8 | $5968K | |
| SHERRILL JOSEPH H JR | Director | 2003-08-07 | BUY | 7,700 | $4.75 | $36.6K |
| SHERRILL JOSEPH H JR | Director | 2003-08-04 | BUY | 2,100 | $4.05 | $8.5K |
| SHERRILL JOSEPH H JR | Director | 2003-08-01 | BUY | 3,600 | $3.99 | $14.4K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked